Us2.ca
Overview
Us2.ai is an FDA-cleared and CE-marked artificial intelligence platform that fully automates echocardiography analysis, transforming cardiac diagnostics. It connects to ultrasound devices and PACS, processing echocardiograms in real time to deliver standardized, clinician-ready reports in seconds, not minutes. Unlike semi-automated tools, Us2.ai provides a complete structured report, including measurements, disease detection, and findings, often with zero clicks.
The platform is designed to improve workflow efficiency, reduce reporting time by up to 70%, and enhance diagnostic accuracy, addressing challenges like sonographer shortages and increasing clinical demands. Us2.ai’s AI-powered software automatically analyzes all heart chambers using both 2D and Doppler views, providing automated estimations of various cardiac structural and functional parameters. It incorporates deep learning pattern recognition with guideline-based echocardiographic measurements for automated detection of conditions such as cardiac amyloidosis, heart failure (HFpEF/HFrEF), pulmonary hypertension, and aortic stenosis.
Us2.ai supports clinical decision-making by providing fully explainable AI outcomes with transparent visual overlays and editable annotations directly from reports. The system integrates seamlessly with existing echo devices, CVIS, EMR, and PACS, offering both cloud and on-premise deployment options to ensure data security and compatibility with various infrastructures. Its technology is validated by peer-reviewed evidence and is used globally to democratize expert-level cardiac diagnostics, making high-quality, consistent, and inexpensive echo analysis accessible to healthcare providers worldwide.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Fully automated echocardiography analysis (zero clicks)
- Real-time processing and structured report generation
- AI-powered disease detection (e.g., Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension)
- Integration with ultrasound devices, PACS, CVIS, and EMR
- Guideline-based measurements and disease indication conclusions
- Explainable AI with editable annotations and visual overlays
- Comprehensive cardiac structural and functional parameters (2D, Doppler, M-mode, strain imaging)
- Cloud and on-premise deployment options
- Enterprise-grade security and compliance (ISO 27001:2022, MDSAP)
- Vendor-neutral platform
Use Cases
- Accelerating cardiac diagnosis and reporting
- Improving workflow efficiency in echo labs
- Standardized echo reporting for clinical trials and research
- Population-level disease screening and retrospective analysis (EHR mining)
- Supporting remote cardiovascular care and resource-limited settings
- Enhancing clinical decision-making for cardiologists and sonographers
What Physicians Need to Know
Us2.ai significantly streamlines echocardiography analysis, reducing reporting time and improving consistency. Physicians can leverage its fully automated, zero-click reports for faster diagnoses and treatment decisions, especially for conditions like cardiac amyloidosis and heart failure. The guideline-aligned outputs and editable annotations ensure clinical control and transparency. Its ability to reanalyze archived studies can help uncover previously undetected diseases, aiding in population-level screening and longitudinal patient tracking. For busy echo labs, it can increase throughput and standardize reporting across institutions.
Us2.ai is designed for seamless integration with existing clinical infrastructure. It connects directly to ultrasound devices, PACS, CVIS, and EMR systems, with deployment options for both cloud and on-premise environments. Key partnerships, such as with Fujifilm (LISENDO 880 ultrasound system), Merative Merge (Merge Cardio), and Aidoc (aiOSu2122), demonstrate its capability to integrate with leading imaging systems and AI platforms, enhancing workflows and expanding its utility within broader cardiac care solutions.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing — Not publicly disclosed |
| Deployment | Cloud, On-premise |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated Us2.ai is FDA 510(k) cleared (K250151) for automated echocardiography analysis, including the detection of cardiac amyloidosis. Us2.v1 received clearance in 2021, Us2.v2 in 2024, and cardiac amyloidosis detection in 2025. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
What the Web Says
Us2.ai is an AI-driven echocardiography reporting software that automates the analysis of cardiac ultrasound images, providing comprehensive, guideline-based reports in seconds. It has received FDA clearance and CE Mark, and its automated measurements have been validated in numerous peer-reviewed studies against expert readers. The platform aims to improve workflow efficiency, reduce clinician workload, and enhance diagnostic accuracy, ultimately supporting better patient care and operational efficiency.
Overall: PositiveStrengths
- Fully automated echocardiography analysis, generating structured reports in seconds.
- Validated accuracy against expert readers in peer-reviewed studies for various cardiac parameters and disease detection.
- Enhances workflow efficiency, reduces reporting time, and decreases clinician fatigue.
- Improves diagnostic accuracy and consistency, especially for conditions like cardiac amyloidosis and aortic stenosis.
- Seamless integration with existing infrastructure (ultrasound devices, PACS, CVIS, EMR) with cloud or on-premise deployment options.
- Preserves clinical autonomy by allowing physicians and sonographers to review and adjust AI-generated measurements.
Limitations
- Some initial concerns from sonographers about AI potentially replacing their roles, though this is addressed as a misconception.
- One physician noted a past challenge with manual data entry of AI measurements into their EMR, though this was resolved by integration with Merge.
- Limited public reviews on platforms like G2 and Capterra specifically for Us2.ai, making it harder to gauge broader user sentiment from these sources.
Based on reviews from: Us2.ai: AI Echocardiography Reporting Software, FDA-Cleared, User Perceptions of AI Echo | Us2.ai, Top 10 Us2.ai Alternatives & Competitors in 2026 - G2, Compare EchoPAC vs. Us2.ai in 2026 - Slashdot, AI in Echo: State-of-the-art Automated Measurement Techniques and Clinical Applications, How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical Workflows, Clinical Evidence & Peer-Reviewed Publications | Us2.ai, AI Echo in Clinical Workflow | Us2.ai, AI-driven tools into echocardiography practice : r/cardiacsonography - Reddit, Peer-Reviewed Study: Novice Users Acquire Diagnostic-Quality Cardiac Ultrasound Images With AI Guidance, Point-of-care AI-enhanced novice echocardiography for screening heart failure (PANES-HF), I tried a lot of AI medical scribes so you don't have to - my honest review : r/medicine - Reddit, Us+AI Reviews & Product Details - G2, 2024 Year in Review | Us2.ai, Capterra: Find The Right Software, AI proved superior in assessing and diagnosing cardiac function when compared with echocardiogram assessments made by sonographers : r/science - Reddit, I tried all the AI medical scribes so you don't have to - my honest review - Reddit, Capterra Reviews & Ratings 2026 - TrustRadius, Capterra Pros and Cons | User Likes & Dislikes - G2, G2 Reviews | Read Customer Service Reviews of www.g2.com - Trustpilot, Capterra Reviews 2026: Details, Pricing, & Features | G2, Top 8 Claude Skills for UI/UX Engineers - Snyk
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Us2.ca
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Us2.ca.
Eyes On Us (Official Visuals ) Navaan Sandhu | Daaku | New Punjabi Songs 2025
Navaan Sandhu
Frequently Asked Questions
Compare Us2.ca
VS
VS
VS
VS
